Luo Mary Z. 4
4 · Amphastar Pharmaceuticals, Inc. · Filed Jan 11, 2024
Insider Transaction Report
Form 4
Luo Mary Z.
DirectorCOO, Chief Scientist, Chairman10% Owner
Transactions
- Sale
Common Stock
2024-01-10$54.89/sh−50,514$2,772,506→ 1,107,052 total - Sale
Common Stock
2024-01-10$57.00/sh−1,716$97,817→ 1,104,416 total - Sale
Common Stock
2024-01-10$55.95/sh−920$51,477→ 1,106,132 total - Sale
Common Stock
2024-01-10$54.32/sh−78,236$4,249,967→ 1,157,566 total
Holdings
- 2,078,718(indirect: See footnote)
Common Stock
- 6,827,679(indirect: See footnote)
Common Stock
- 5,000(indirect: See footnote)
Common Stock
Footnotes (8)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.67 to $54.665, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.67 to $55.66, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.675 to $56.52, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.97 to $57.26, inclusive.
- [F6]The securities are held of record by Jack Y. Zhang. The reporting persons are husband and wife.
- [F7]The shares are held of record by Applied Physics & Chemistry Laboratories, Inc., of which the reporting persons and The Bill Luobei Zhang 2004 Irrevocable Trust are the sole owners.
- [F8]The shares are held of record by the reporting persons' son. The reporting persons disclaim beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose.